What is the address of Dokter Gysemans Willem, Pediater?

The registered office of Dokter Gysemans Willem, Pediater is located at Hallaarstraat(ITE) 72, 2222 Heist-op-den-Berg.

Is Dokter Gysemans Willem, Pediater still active?

Yes. According to the CBE (18 September 2026) Dokter Gysemans Willem, Pediater is active, legal situation “Normale toestand”, started on 25 June 2020.

Is Dokter Gysemans Willem, Pediater registered on Peppol?

Yes, Dokter Gysemans Willem, Pediater is registered on the Peppol network with ID 0208:0748956596.

What is the enterprise number of Dokter Gysemans Willem, Pediater?

The enterprise number of Dokter Gysemans Willem, Pediater is BE0748956596.

When was Dokter Gysemans Willem, Pediater founded?

Dokter Gysemans Willem, Pediater was founded on 25 June 2020.

Who are the directors of Dokter Gysemans Willem, Pediater?

According to the 2025 annual accounts, the directors of Dokter Gysemans Willem, Pediater are: Willem Gysemans.

Is Dokter Gysemans Willem, Pediater a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 June 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Gysemans Willem, Pediater make in 2025?

Dokter Gysemans Willem, Pediater posted a profit after taxes of € 142,083 in financial year 2025.

What is the revenue of Dokter Gysemans Willem, Pediater?

As a small company, Dokter Gysemans Willem, Pediater is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 197,046.

Dokter Gysemans Willem, Pediater (Private Limited)

Dossier Dokter Gysemans Willem, Pediater, printed on 18 September 2026 from databakkes.be/en/0748956596/dokter-gysemans-willem-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dokter Gysemans Willem, Pediater from Heist-op-den-Berg, company number BE0748956596, closed financial year 2025 with a result of € 142,083 after tax. For that financial year Dokter Gysemans Willem, Pediater recorded a gross margin of € 197,046 and equity of € 37,083. Compared with financial year 2024, the result moved from € 160,200 to € 142,083. The company is profitable. The buffer shrank hard: equity is 81 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Shrank hard

€ 37,083

▼ 81% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 142,083

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 50,811

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 297,068 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 13,691

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 16,204

▼ 41% vs 2024

€ 11,395 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 1,002

▼ 55% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 211,808 Gross margin 2022: € 211,808 First fiscal year in the series	€ 224,093 Gross margin 2023: € 224,093 ▲ 6% vs 2022 (€ 211,808) Favourable step	€ 222,122 Gross margin 2024: € 222,122 ▼ 1% vs 2023 (€ 224,093) Unfavourable step	€ 197,046 Gross margin 2025: € 197,046 ▼ 11% vs 2024 (€ 222,122) Unfavourable step	▼ 11%
Profit after taxes	€ 154,981 Profit after taxes 2022: € 154,981 First fiscal year in the series	€ 162,504 Profit after taxes 2023: € 162,504 ▲ 5% vs 2022 (€ 154,981) Favourable step	€ 160,200 Profit after taxes 2024: € 160,200 ▼ 1% vs 2023 (€ 162,504) Unfavourable step	€ 142,083 Profit after taxes 2025: € 142,083 ▼ 11% vs 2024 (€ 160,200) Unfavourable step	▼ 11%
Equity	€ 459,364 Equity 2022: € 459,364 First fiscal year in the series	€ 231,868 Equity 2023: € 231,868 ▼ 50% vs 2022 (€ 459,364) Unfavourable step	€ 192,068 Equity 2024: € 192,068 ▼ 17% vs 2023 (€ 231,868) Unfavourable step	€ 37,083 Equity 2025: € 37,083 ▼ 81% vs 2024 (€ 192,068) Unfavourable step	▼ 81%
Total debts	€ 57,472 Total debts 2022: € 57,472 First fiscal year in the series	€ 45,008 Total debts 2023: € 45,008 ▼ 22% vs 2022 (€ 57,472) Favourable step	€ 32,867 Total debts 2024: € 32,867 ▼ 27% vs 2023 (€ 45,008) Favourable step	€ 132,766 Total debts 2025: € 132,766 ▲ € 99,899 vs 2024 (€ 32,867) Unfavourable step	▲ € 99,899
Cash	€ 246,086 Cash 2022: € 246,086 First fiscal year in the series	€ 28,768 Cash 2023: € 28,768 ▼ 88% vs 2022 (€ 246,086) Unfavourable step	€ 78,551 Cash 2024: € 78,551 ▲ 173% vs 2023 (€ 28,768) Favourable step	€ 50,811 Cash 2025: € 50,811 ▼ 35% vs 2024 (€ 78,551) Unfavourable step	▼ 35%
Retained profit	€ 449,364 Retained profit 2022: € 449,364 First fiscal year in the series	€ 221,868 Retained profit 2023: € 221,868 ▼ 51% vs 2022 (€ 449,364) Unfavourable step	€ 182,068 Retained profit 2024: € 182,068 ▼ 18% vs 2023 (€ 221,868) Unfavourable step	€ 27,083 Retained profit 2025: € 27,083 ▼ 85% vs 2024 (€ 182,068) Unfavourable step	▼ 85%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 390,000 Dividend 2023: € 390,000 Unchanged (€ 0) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▼ 49% vs 2023 (€ 390,000) Unchanged	€ 297,068 Dividend 2025: € 297,068 ▲ 49% vs 2024 (€ 200,000) Unchanged	▲ 49%
Bank debt	€ 49,191 Bank debt 2022: € 49,191 First fiscal year in the series	€ 38,390 Bank debt 2023: € 38,390 ▼ 22% vs 2022 (€ 49,191) Favourable step	€ 27,397 Bank debt 2024: € 27,397 ▼ 29% vs 2023 (€ 38,390) Favourable step	€ 16,204 Bank debt 2025: € 16,204 ▼ 41% vs 2024 (€ 27,397) Favourable step	▼ 41%
Balance sheet total	€ 516,836 Balance sheet total 2022: € 516,836 First fiscal year in the series	€ 276,876 Balance sheet total 2023: € 276,876 ▼ 46% vs 2022 (€ 516,836) Unchanged	€ 224,935 Balance sheet total 2024: € 224,935 ▼ 19% vs 2023 (€ 276,876) Unchanged	€ 169,849 Balance sheet total 2025: € 169,849 ▼ 24% vs 2024 (€ 224,935) Unchanged	▼ 24%

Key figures of Dokter Gysemans Willem, Pediater, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter Gysemans Willem, Pediater?

What happened at Dokter Gysemans Willem, Pediater in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 142,083 (▼ 11% vs 2024). Source: NBB ↗
Jun 25, 2020 New establishment in Heist-op-den-Berg. KBO
2020 Willem Gysemans became a director. NBB
Jun 25, 2020 Start of the company according to the CBE. KBO

In short

From € 154,981 profit in 2022 to € 142,083 profit in 2025.

Paid € 185,004 in corporate taxes since 2022.

Best year ever: 2023, with € 162,504 profit.

Paid out € 887,068 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Gysemans Willem, Pediater? We notify you, reason included.

Follow Dokter Gysemans Willem, Pediater

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Willem Gysemans

Dokter Gysemans Willem, Pediater

Behind Dokter Gysemans Willem, Pediater is Willem Gysemans.

See the full network in the app

Directors

According to the 2025 annual accounts

Willem Gysemans

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Hallaarstraat(ITE) 72

2222 Heist-op-den-Berg

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0748.956.596
VAT number: BE 0748.956.596
Registered office: Hallaarstraat(ITE) 72, 2222 Heist-op-den-Berg
Names & denominations: Dokter Gysemans Willem, Pediater
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 June 2020
Peppol: Active · Active since 6 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗